Close
ACHEMA MIDDLE EAST 2026

With Discovery, Skullcap A Perfect Fit For Modern Medicine

A collaboration between Chinese researchers and UK researchers has led to the unlocking of facilities related to evolutionary secrets that help the medicinal herb...

New Algorithms That Lead To Personalized Cancer Treatments

When single-cell data is combined with a self-learning algorithm, it is a revelation as to how structural changes can go on to trigger cancer....

High Mortality Due To VEXAS Than What Was Previously Thought

As per a recent study that was published in JAMA, a not so well-known syndrome with high mortality has a much higher prevalence than...

WHO Asks For Supply Chain Alterations To Fight Contamination

The World Health Organization has urged regulators, suppliers, as well as medicine manufacturers to take strict steps against medicines in the supply chain that...

Large DNA Sequences Insertion With New Method A Success

Recent work by researchers at Massachusetts General Hospital (MGH) in the US has improved the accuracy of inserting long DNA fragments into genomes. This method...

Antibiotic Shortage In The EU Has Become A Cause For Worry

The current EU antibiotic shortages are being closely watched, according to the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), which...

FDA Intends To Make The Covid-19 Vaccine Process Simpler

The US FDA intends to simplify the COVID-19 vaccine process to make it look more like what happens in case of flu vaccine.This could...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...